Pimtrea Kit
Product Images NDC 16714-404

14 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pimtrea (NDC 16714-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram showing the molecular structures of desogestrel and ethinyl estradiol. The image includes the chemical formulas C22H30O for desogestrel and C20H24O2 for ethinyl estradiol, illustrating their distinct steroid frameworks.*
FDA Label Image

Table1 (Table1)

Table1 (Table1)
A data table presenting mean (SD) pharmacokinetic parameters of desogestrel/ethinyl estradiol and ethinyl estradiol tablets over a 28-day dosing period in the third cycle (n=17). It lists variables such as dose (mg), Cmax (pg/mL), Tmax (h), t1/2 (h), AUC0-24 (pg/mL*hr), and CL/F (L/h) for etonogestrel and ethinyl estradiol on specified days.*
FDA Label Image

Table2 (Table2)

Table2 (Table2)
A data table showing the percentage of women experiencing an unintended pregnancy during the first year of typical and perfect use of various contraceptive methods, along with the percentage continuing use at one year. Methods include Chance, Spermicides, Periodic abstinence, Withdrawal, Cap, Sponge, Diaphragm, Condom, Pill, IUD, Depo-Provera, Norplant, female and male sterilization, categorized with relevant percentage data.*
FDA Label Image

Figure 11 (Figure 11)

Figure 11 (Figure 11)
A bar chart illustrating circulatory disease mortality rates per 100,000 woman-years, segmented by age groups (15-24, 25-34, 35-44, 45+), smoking status, and oral contraceptive use. The chart compares mortality rates between ever-users and controls among smokers and non-smokers, with data showing higher mortality in older age groups, especially among smokers who are ever-users.*
FDA Label Image

Table (Table)

Table (Table)
A data table presenting the annual number of birth-related or method-related deaths per 100,000 non-sterile women, categorized by fertility control method and age group (15 to 44 years). The table compares various methods including no fertility control, oral contraceptives (smokers and non-smokers), IUD, condom, diaphragm/spermicide, and periodic abstinence, with notes indicating which deaths are birth-related or method-related.*
FDA Label Image

Fig-2 (Fig 2)

Fig-2 (Fig 2)
A forest plot chart showing effect estimates comparing ever combined oral contraceptives (COC) use vs. never use and current COC use vs. never use from various studies between 2002 and 2017. The plot includes odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals, mapped on an effect estimate scale from -1.50 to 2.00.*
FDA Label Image
FDA Label Image

Figure 01-1 (Figure 01 1)

Figure 01-1 (Figure 01 1)
PIMTREA kit blister card displaying a 28-tablet arrangement with rows labeled by weeks and columns by days (Sunday through Saturday). The card is color-coded with dark blue, white, and green tablets, and features directions to take dark blue tablets first. The label includes storage instructions and manufacturer information for Northstar Rx LLC Memphis, TN.*
FDA Label Image

Figure-015-1 (Figure 015 1)

Figure-015-1 (Figure 015 1)
An instructional illustration showing how to use day labels with a blister pack. The image features a hand peeling a strip of day labels (MON, TUE, WED, THU, FRI, SAT, SUN) to place on the blister pack's designated area. The blister pack includes circular tablets and printed instructions, demonstrating correct labeling for user adherence.*
FDA Label Image

Table4-1 (Table4 1)

Table4-1 (Table4 1)
A data table showing the annual number of birth-related or method-related deaths per 100,000 non-sterile women by fertility control method and age group. The table compares outcomes for methods such as no fertility control, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence across age ranges 15 to 44 years. Footnotes clarify that some deaths are birth related and others method related.*
FDA Label Image

Image-015-1 (Image 015 1)

Image-015-1 (Image 015 1)
Illustration showing how to correctly apply a day label to a blister pack of PIMTREA oral contraceptive tablets. The image includes instructions to pick the correct day label and peel it to place on the blister pack, with an example of tablet colors and layout.*
FDA Label Image

Image-016-1 (Image 016 1)

Image-016-1 (Image 016 1)
PIMTREA oral contraceptive kit blister pack with 28 tablets arranged by week and day. The pack includes dark blue, white, and green tablets, color-coded and labeled by day of the week (Sunday through Saturday) for four weeks. Instructions and storage information are printed on the blister pack panel along with the labeler Northstar Rx LLC, Memphis, TN.*
FDA Label Image

Logo (copy) (Logo (copy))

FDA Label Image

Carton-pimtrea-d (Carton Pimtrea D 1)

Carton-pimtrea-d (Carton Pimtrea D 1)
PIMTREA kit containing Desogestrel/Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP with strengths of 0.15 mg/0.02 mg and 0.01 mg respectively. The packaging shows 6 blister cards of 28 tablets each and includes a purple flower graphic. Manufactured by Northstar Rx LLC, the label includes product usage note, storage instructions, and barcodes along with the NDC 16714-404.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.